Literature DB >> 534806

Further observations on the duration of depot neuroleptic maintenance therapy in schizophrenia.

D A Johnson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 534806     DOI: 10.1192/bjp.135.6.524

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  7 in total

Review 1.  [Pharmacotherapy for schizophrenia].

Authors:  W W Fleischhacker; W Hummer
Journal:  Nervenarzt       Date:  2006-11       Impact factor: 1.214

Review 2.  Pharmacological treatment of patients with schizophrenia. Past and present problems and potential future therapy.

Authors:  D A Johnson
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

Review 3.  Drug treatment of schizophrenia in the 1990s. Achievements and future possibilities in optimising outcomes.

Authors:  W W Fleischhacker; M Hummer
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

4.  Low dose maintenance medication for schizophrenia.

Authors:  R Manchanda; S R Hirsch
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-30

5.  Assessment and treatment selection for "revolving door" inpatients with schizophrenia.

Authors:  P Weiden; W Glazer
Journal:  Psychiatr Q       Date:  1997

6.  Hypouricemic effect of zuclopenthixol: a potential marker of drug compliance?

Authors:  M Bloch; E Gur; A Y Shalev
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 7.  Depot antipsychotic drugs. Place in therapy.

Authors:  J M Davis; L Matalon; M D Watanabe; L Blake; L ] Metalon L [corrected to Matalon
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.